atorvastatin + placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Atherosclerotic Vascular Disease
Conditions
Atherosclerotic Vascular Disease
Trial Timeline
Aug 1, 2008 → Dec 1, 2009
NCT ID
NCT00703261About atorvastatin + placebo
atorvastatin + placebo is a phase 1 stage product being developed by Merck for Atherosclerotic Vascular Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00703261. Target conditions include Atherosclerotic Vascular Disease.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00703261 | Phase 1 | Completed |
Competing Products
20 competing products in Atherosclerotic Vascular Disease